Literature DB >> 23765112

Underreporting of liver transplant waitlist removals due to death or clinical deterioration: results at four major centers.

David Goldberg1, Benjamin French, James Trotter, Kirti Shetty, Thomas Schiano, K Rajender Reddy, Scott D Halpern.   

Abstract

BACKGROUND: Few studies have evaluated the accuracy of United Network for Organ Sharing (UNOS) or Scientific Registry of Transplant Recipients data among patients listed for liver transplantation. Of particular importance for transplant policy and practice is whether patients' outcomes are coded properly.
METHODS: Using data from four transplant centers, we identified all liver transplant candidates removed from the waitlist from February 27, 2002 to July 24, 2010, with a specific focus the removal code of "other."
RESULTS: Among nontransplanted patients at these centers, 2206 patients were removed for death or clinical deterioration. Of these, 8.6% (189 of 2206) were misclassified; they were assigned the UNOS removal code of "other." Among these 189 misclassified patients, 128 became medically unsuitable, 35 died, and 26 became too sick to transplant. Nearly one-half (46.8%) of misclassified patients were removed due to advanced hepatocellular carcinoma. Among true waitlist removals for death, only 35 of 1593 (2.2%) were misclassified. Conversely, of true removals for clinical deterioration, 154 of 612 (25.2%) were misclassified, with significant (P < 0.001) center variation: 4.4% (Baylor), 8.0% (Georgetown), 32.6% (University of Pennsylvania), and 45.0% (Mount Sinai). Extrapolating these data to the entire United States, if "other" patients who truly died or clinically deteriorated were recoded appropriately, there would be an additional 2525 (95% confidence interval, 2046-3102) patients removed from the waitlist due to death (331) or clinical deterioration (2194) since 2002. DISCUSSION: A substantial proportion of patients truly removed from the waitlist for death or clinical deterioration were misclassified as "other." Thus, analyses using the UNOS or the Scientific Registry of Transplant Recipients database may underestimate the true proportion of patients removed from the waitlist for clinical deterioration.

Entities:  

Mesh:

Year:  2013        PMID: 23765112      PMCID: PMC3715579          DOI: 10.1097/TP.0b013e3182970619

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Accounting for response misclassification and covariate measurement error improves power and reduces bias in epidemiologic studies.

Authors:  Dunlei Cheng; Adam J Branscum; James D Stamey
Journal:  Ann Epidemiol       Date:  2010-07       Impact factor: 3.797

2.  Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.

Authors:  David Goldberg; Benjamin French; Peter Abt; Sandy Feng; Andrew M Cameron
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

3.  Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry.

Authors:  B W Gillespie; R M Merion; E Ortiz-Rios; L Tong; A Shaked; R S Brown; A O Ojo; P H Hayashi; C L Berg; M M Abecassis; A S Ashworth; C E Friese; J C Hong; J F Trotter; J E Everhart
Journal:  Am J Transplant       Date:  2010-02-25       Impact factor: 8.086

4.  Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit.

Authors:  Michael R Lucey; Douglas E Schaubel; Mary K Guidinger; Santiago Tome; Robert M Merion
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

5.  Disparities in liver transplantation before and after introduction of the MELD score.

Authors:  Cynthia A Moylan; Carla W Brady; Jeffrey L Johnson; Alastair D Smith; Janet E Tuttle-Newhall; Andrew J Muir
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

  5 in total
  16 in total

Review 1.  Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.

Authors:  Mary D Cannon; Paul Martin; Andres F Carrion
Journal:  Dig Dis Sci       Date:  2020-01       Impact factor: 3.199

2.  Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis-implications for surveillance and future pharmacotherapy.

Authors:  Michael P Johnston; Janisha Patel; Christopher D Byrne
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

3.  MELD exceptions for portopulmonary hypertension: current policy and future implementation.

Authors:  D S Goldberg; S Batra; S Sahay; S M Kawut; M B Fallon
Journal:  Am J Transplant       Date:  2014-07-01       Impact factor: 8.086

4.  Patients With Acute on Chronic Liver Failure Grade 3 Have Greater 14-Day Waitlist Mortality Than Status-1a Patients.

Authors:  Vinay Sundaram; Parth Shah; Robert J Wong; Constantine J Karvellas; Brett E Fortune; Nadim Mahmud; Alexander Kuo; Rajiv Jalan
Journal:  Hepatology       Date:  2019-05-17       Impact factor: 17.425

5.  Predictors of Waitlist Mortality in Portopulmonary Hypertension.

Authors:  Michael J Krowka; Richard N Channick; Hilary M DuBrock; David S Goldberg; Norman L Sussman; Sonja D Bartolome; Zakiyah Kadry; Reena J Salgia; David C Mulligan; Walter K Kremers; Steven M Kawut
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

6.  Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.

Authors:  Allison J Kwong; Jennifer C Lai; Jennifer L Dodge; John P Roberts
Journal:  Liver Transpl       Date:  2015-11       Impact factor: 5.799

7.  Sex-based disparities in delisting for being "too sick" for liver transplantation.

Authors:  Giuseppe Cullaro; Monika Sarkar; Jennifer C Lai
Journal:  Am J Transplant       Date:  2017-12-28       Impact factor: 8.086

8.  Validating Early Post-Transplant Outcomes Reported for Recipients of Deceased Donor Kidney Transplants.

Authors:  Vishnu S Potluri; Chirag R Parikh; Isaac E Hall; Joseph Ficek; Mona D Doshi; Isabel Butrymowicz; Francis L Weng; Bernd Schröppel; Heather Thiessen-Philbrook; Peter P Reese
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-14       Impact factor: 8.237

9.  Poor Performance Status Is Associated With Increased Mortality in Patients With Cirrhosis.

Authors:  Eric S Orman; Marwan Ghabril; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-01       Impact factor: 11.382

10.  Sex Differences in Portopulmonary Hypertension.

Authors:  Hilary M DuBrock; Rodrigo Cartin-Ceba; Richard N Channick; Steven M Kawut; Michael J Krowka
Journal:  Chest       Date:  2020-08-13       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.